Goldman Sachs Group Inc Hexo Corp. Transaction History

Goldman Sachs Group Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 May 14, 2024	SELL	$0.17 - $0.26 $6,097 - $9,325	-35,868 Reduced 57.18%	26,859 $5,000
Q3 2022 Nov 10, 2022	SELL	$0.17 - $0.26 $6,097 - $9,325	-35,868 Reduced 57.18%	26,859 $0
Q2 2022 May 14, 2024	BUY	$0.2 - $0.61 $12,545 - $38,263	62,727 New	62,727 $13,000
Q2 2022 Aug 15, 2022	SELL	$0.2 - $0.61 $119,472 - $364,389	-597,360 Reduced 90.5%	62,727 $13,000
Q1 2022 May 16, 2022	SELL	$0.48 - $0.74 $349,730 - $539,168	-728,606 Reduced 52.47%	660,087 $409,000
Q4 2021 Feb 14, 2022	BUY	$0.7 - $1.94 $271,754 - $753,148	388,221 Added 38.8%	1,388,693 $970,000
Q3 2021 Nov 10, 2021	BUY	$1.82 - $5.71 $1.82 Million - $5.71 Million	1,000,472 New	1,000,472 $1.84 Million

23.7K

Ticker HEXO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 601,395,008
Description
HEXO Corp., through its subsidiaries, produces, markets, and sells cannabis in Canada. The company offers its adult-use and medical products under the HEXO brand name. It also provides cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brands; and cannabis products under UP Cannabis, Original Stash, and Up b...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.